Potential Antibiotic-Drug Interactions: Analysis of Pediatric Patient Prescriptions at Omnia Farma Pharmacy Purwokerto

https://doi.org/10.22146/jmpf.101427

Esti Dyah Utami(1*), Farah Ayu Maharani(2), Heny Ekowati(3), Masita Wulandari Suryoputri(4)

(1) Laboratory of Pharmacology and Clinical Pharmacy, Faculty of Health Sciences, Universitas Jenderal Soedirman, Purwokerto
(2) Department of Pharmacy, Faculty of Health Sciences, Universitas Jenderal Soedirman, Purwokerto
(3) Department of Pharmacy, Faculty of Health Sciences, Universitas Jenderal Soedirman, Purwokerto
(4) Laboratory of Pharmacology and Clinical Pharmacy, Faculty of Health Sciences, Universitas Jenderal Soedirman, Purwokerto
(*) Corresponding Author

Abstract


Background: The use of drugs in pediatric patients requires special attention because pediatrics have physiological and anatomical differences with adults. Children are more susceptible to infectious diseases and often get antibiotic therapy and other symptomatic drugs to support recovery, thus increasing the potential for drug interactions.

Objectives: The study aimed to analyze the incidence of potential antibiotic drug interactions prescribed to pediatric patients at Omnia Farma Pharmacy Purwokerto. 

Methods: This observational study was conducted retrospectively by collecting prescription data of pediatric patients aged 0-18 years at Omnia Farma Pharmacy Purwokerto from January to December 2023 using a simple random sampling method. Data were analyzed descriptively using the standard of the Lexicomp Interaction Checker database and other scientific literature. 

Results: There were 286 patient prescriptions that met the inclusion criteria. The majority of patients were male, aged 1-5 years, with the most prescribed antibiotic being amoxicillin (73.13%). The study only found potential drug interactions in 12 antibiotic prescriptions (4.20%), of which 50% were interactions between azithromycin and salbutamol. Most of the potential antibiotic-drug interactions found were of minor severity (91.67%), with pharmacodynamic interaction mechanisms (83.33%).

Conclusion: The antibiotic prescriptions given to pediatric patients at Omnia Farma Pharmacy were quite good in terms of the minimal number of potential drug interactions found. Special attention to the therapy of pediatric patients through the collaboration of doctors and pharmacists is important to help patients get optimal therapy.


Keywords


Antibiotics; Pediatrics; Pharmacy; Potential Drug Interactions; Prescriptions

Full Text:

PDF


References

  1. Kemenkes RI. Permenkes RI Nomor 28 Tahun 2-21 Tentang Pedoman Penggunaan Antibiotik. Kementrian Kesehatan Republik Indonesia; 2021.
  2. Katarnida SS, Dewi M, Yusticia K. Evaluasi Penggunaan Antibiotik Secara Kualitatif di RS Penyakit Infeksi Sulianti Saroso, Jakarta. Sari Pediatri. 2014;15.
  3. WHO. Antimicrobial resistance. World Health Organization. https://www.who.int/news-room/fact-sheet/detail/antimicrobial-resistance,
  4. Ningtyas MSS. Pola Penggunaan Antibiotik Di Apotek “X” Kabupaten Kepulauan Talaud Sulawesi Utara. Soc Clin Pharm Indones J. 2023;8(1):1-7. doi:10.52447/scpij.v8i2.5671
  5. Dian Suryani V, Umilia Purwanti N, Nurmainah N. Narrative Review : Efek Samping Penggunaan Antibiotik Azitromycin Pada Pasien Covid-19. Indones J Pharm Educ. 2023;3(2). doi:10.37311/ijpe.v3i2.20720
  6. Batchelor HK, Marriott JF. Paediatric pharmacokinetics: key considerations. Br J Clin Pharmacol. 79(3):395–404. doi:10.1111/bcp.12267
  7. Hendera RS. Analisis risiko interaksi obat terhadap resep pasien klinik anak di rumah sakit di Banjarmasin. J Curr Pharm Sci. 2(2):148–153.
  8. Farida Y. Studi Potensi Interaksi Antibiotik Dengan Obat Lain Pada Peresepan Pasien Pneumonia Di Intensive Care Unit. J Farm Indones. 2022;19(1):1-13. doi:10.31001/jfi.v19i1.816
  9. Pengurus Besar Ikatan Dokter Indonesia. Panduan Praktik Klinis Bagi Dokter Edisi Revisi Tahun 2014 Di Fasilitas Pelayanan Kesehatan Primer.
  10. Atmaja SP, Kurniawaty AY, Kristariyanto YA. Interaksi Antibiotik Dengan Obat Lainnya Pada Pasien Pediatri: Sebuah Kajian Naratif.
  11. Baxter K. Stokley’s Drug Interactions. 9th ed. Pharmaceutical Press
  12. Bebitoğlu BT. Evaluation of potential drug-drug interactions in a pediatric population. Turk Pediatr Ars. 55(1):30–38. doi:10.14744/TurkPediatriArs.2019.60938.
  13. Salerno SN, Burckart GJ, Huang SM, Gonzalez D. Pediatric Drug-Drug Interaction Studies: Barriers and Opportunities. Clin Pharmacol Ther. 105(5):1067–1070.
  14. Barliana MI, Sari DR, Faturrahman M. Analisis Potensi Interaksi Obat dan Manifestasi Klinik Resep Anak di Apotek Bandung. J Farm Klin Indones. 2013;2(3):121-126.
  15. Nursanti F. Potensi Interaksi Obat Pada Resep Pasien Pediatri Studi Retrospektif Di 3 Apotek Kota Surakarta Periode Juli-Desember 2013. Skripsi. Fakultas Farmasi Universitas Muhammadiyah Surakarta
  16. Reyaan IBM, Kuning C, Adnyana IK. Studi potensi interaksi obat pada resep polifarmasi di dua apotek Kota Bandung. J Manag Pharm Pract. 11(3):145–152.
  17. Dariyati N, Suwarni S, Pitarisa AP, Serang Y, Leki KGB. Hubungan Polifarmasi dan Temuan Potensi Interaksi Obat pada Peresepan Pasien Anak di Apotek Bukit Sari Semarang Tahun 2021. J Farm Sains Indones. 5(2):14–19.
  18. Astiti PMA, Mukaddas A, Illah SA. Identifikasi Drug Related Problems (DRPs) pada Pasien Pediatri Pneumonia Komunitas di Instalasi Rawat Inap RSD Madani Sulawesi Tengah. J Farm Galen. 3(1):57–63.
  19. Wibowo MINA, Pratiwi RA, Sundhani E. Studi Prospektif Potensi Interaksi Obat Golongan Antibiotika pada Pasien Pediatri di Rumah Sakit Ananda Purwokerto. Pharm J Farm Indones. 15(2):243–256.
  20. Rizqiah A, Damayanti A. Review Interaksi Obat-Obat Potensial Terapi Antibiotik Pada Infeksi Saluran Pernafasan Pasien Anak Rawat Inap Di Rumah Sakit. J Pharm Sci Technol. 2023;3(2):209-216. doi:10.30649/pst.v3i2.41
  21. Tatro DS. Drug Interaction Facts, The Authority on Drug Interactions. California: Wolters Kluwer
  22. Anker M. Addressing sex and gender in epidemic-prone infectious diseases. 2007. World Health Organization, Geneva, Switzerland.
  23. Ober C, Loisel DA, Gilad Y. Sex-specific genetic architecture of human disease. Nat Rev Genet. 2008;9:911-22.
  24. Maximilian M, Goulder PJR. Sex Differences in Pediatric Infectious Diseases. The Journal of Infectious Diseases. 2014;209(S3):S120-126.
  25. Araneo BA, Dowell T, Diegel M, Daynes RA. Dihydrotestosterone exerts a depressive infuence on the production of interleukin-4 (IL-4), IL-5, and gamma-interferon, but not IL-2 by activated murine T cells. Blood. 1991;78:688-699.
  26. Straub RH. The complex role of estrogens in infammation. Endocr Rev. 2007;28:521-74.
  27. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095-2128.
  28. Timur WW, Hakim L, Rahmawati F. Kajian Drug Related Problems Penggunaan Antibiotik Pada Pasien Pediatrik Di RSUD Kota Semarang. J Farm Sains dan Prakt. III(2):47–53.
  29. Rukminingsih F, Apriliyani A. Analisis Penggunaan Antibiotik Pada Pasien Anak Di Ruang Theresia Rumah Sakit St. Elisabeth Semarang Dengan Metode Atc/Ddd. J Ris Kefarmasian Indones. 2021;3(1):26-34. doi:10.33759/jrki.v3i1.110.
  30. Kline JM, Wietholter JP, Kline VT, Confer J. Pediatric Antibiotic Use: A Focused Review of Fluoroquinolones and Tetracyclines. US Pharm. 2012;37(8):56-59.
  31. Ho PL, Tse WS, Tsang KW, et al. Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: a case-control study. Clin Infect Dis. 2001;32:701-707.
  32. Yee CL, Duffy C, Gerbino PG, et al. Tendon or joint disorders in children after treatment withfluoroquinolones or azithromycin. Pediatr Infect Dis J. 2002;21:525-529.
  33. Katzung BG. Basic and Clinical Pharmacology. 14th ed. Mc Graw-Hill Education
  34. ANGIN MP, Yasir AS, Wafika U. Evaluasi Rasionalitas Penggunaan Antibiotik Pada Pasien Anak Diagnosa Ispa Dengan Metode Gyssens Di Instalasi Rawat Jalan Puskesmas Pugung Raharjo Lampung Timur. J Farm Malahayati. 2022;4(2):185-193. doi:10.33024/jfm.v4i2.5286
  35. Tuloli TS, Akuba J, Djuwarno EN, Makkulawu A, Ahmad RA. Profil Penggunaan Obat Antibiotik pada Penderita Infeksi Saluran Pernapasan Akut (ISPA) di Puskesmas Kabupaten Gorontalo. J Syifa Sci Clin Res. 6(1).
  36. Raini M. Antibiotik Golongan Fluorokuinolon: Manfaat dan Kerugian. Media Litbangkes. 2016;26(3):163-174.
  37. Bradley JS, Jackson MA, Committee on Infectious Diseases, American Academy of Pediatrics. The use of systemic and topical fluoroquinolones. Pediatrics. 2011;128:e1034-e1045.
  38. American Academy of Pediatrics Committee on Infectious Diseases. The use of systemic fluoroquinolones. Pediatrics. 2006;118:1287-1292.
  39. Adefurin A, Sammons H, Jacqz-Aigrain E, Choonara I. Ciprofloxacin safety in paediatrics: a systematic review. Arch Dis Child. 2011;96:874-880.
  40. Kato M. Chondrotoxicity of Quinolone Antimicrobial Agents. J.Toxicol Pathol. 2008;21:123-131.
  41. Wolters Kluwer. Lexicomp Drug Interactions Analysis. Published online 2023. https://www.wolterskluwer.com/en/solutions/lexicomp/resources/lexicomp-user-academy-old/drug-interactions-analysis
  42. Bailie GR, Johnson CA, Mason NA, Peter WL St. MED Facts Pocket Guide of Drug Interactions Second Edition.; 2009.
  43. Drugscom. Drugs Interaction Checker. https://www.drugs.com/drug_interactions.html.
  44. Melgar Quicaño LA, Chipa Ccasani F. Congenital long QT syndrome. Arch Peru Cardiol y Cir Cardiovasc. 2021;2(1):49-57. doi:10.47487/apcyccv.v2i1.125
  45. Santoso SB, Metty A. Potensi Interaksi Antibiotik Dengan Obat Penyerta Pada Peresepan Pasien Ispa Dan Ppok. J Ilmu Farm (Journal Pharm Sci. 2017;9(December):57-64.
  46. Muslim Z, Novrianti A, Irnameria D, et al. Resistance Test of Bacterial Causes of Urinary Tract Infection Against Ciprofloxacin and Ceftriaxone Antibiotics. J Teknol dan Seni Kesehat. 2020;11(2):203-212. https://doi.org/10.36525/sanitas.2020.19
  47. Fajriani MN, INDONESIA UM. Perbandingan Efektivitas Pemberian Premedikasi Deksametason dan Ondansetron Untuk Mencegah Mual dan Muntah Pasca Operasi dengan Anestesi Umum Di Rumah Sakit Ibnu Sina.
  48. Suryani VD, Purwanti NU, Nurmainah N. Narrative Review: Efek Samping Penggunaan Antibiotik Azitromycin Pada Pasien Covid-19. Indones J Pharm Educ. 3(2).
  49. Hidayati NR, Indriaty S, Bachtiar A, Setyaningsih I, Zamzam MY, Michelle V. Kajian Potensi Interaksi Obat Pada Pasien Infeksi Saluran Kemih Di Instalasi Rawat Inap Rumah Sakit Ciremai Cirebon. Med Sains J Ilm Kefarmasian. 7(1):9–20.
  50. Anggita D, Nurisyah S, Wiriansya EP. Mekanisme Kerja Antibiotik. UMI Med J. 7(1):46–58.
  51. Sunaryo TT, Ariastuti R, Khusna K. Gambaran Penggunaan Obat Diare pada Pasien Dewasa di Puskesmas Ngemplak Boyolali Tahun 2021.
  52. Medscapecom. Drugs Interaction Checker. https://reference.medscape.com/drug-interactionchecker.
  53. Tussoleha EA. Tingkat Pengetahuan Ibu terhadap Penggunaan Antibiotik pada Anak-Anak di Klinik Satelit Kalimantan Gresik,. Published online 2020:1-17. eprints.umg.ac.id/3960/6/f. BAB 2.pdf
  54. Admaja W, Marhenta YB, Amalia V, Syiva N. Analisis Efektivitas Biaya Penggunaan Omeprazole dan Ranitidin Pada Pasien Gastritis Rawat Inap di RS X Kabupaten Kediri. J Pharma Bhakta. 2023;3(1):17-26.
  55. Dr. Apt. Diana Laila Ramatillah MF. Buku Ajar Interaksi Obat. UTA Press; 2020.
  56. Aghili M, Kasturirangan MN. Management of Drug-Drug Interactions among Critically Ill Patients with Chronic Kidney Disease: Impact of Clinical Pharmacist’s Interventions. Indian J Crit Care Med. 25(11):1226–1231.



DOI: https://doi.org/10.22146/jmpf.101427

Article Metrics

Abstract views : 344 | views : 230

Refbacks

  • There are currently no refbacks.


Copyright (c) 2026 JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice)

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

©Jurnal Manajemen dan Pelayanan Farmasi
Faculty of Pharmacy
Universitas Gadjah Mada
Creative Commons License
View My Stats